Global Immuno-Oncology Treatment Supply, Demand and Key Producers, 2023-2029

Page: 114

Published Date: 13 Feb 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

This report studies the global Immuno-Oncology Treatment demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Immuno-Oncology Treatment, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Immuno-Oncology Treatment that contribute to its increasing demand across many markets.

The global Immuno-Oncology Treatment market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Highlights and key features of the study
Global Immuno-Oncology Treatment total market, 2018-2029, (USD Million)
Global Immuno-Oncology Treatment total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Immuno-Oncology Treatment total market, key domestic companies and share, (USD Million)
Global Immuno-Oncology Treatment revenue by player and market share 2018-2023, (USD Million)
Global Immuno-Oncology Treatment total market by Type, CAGR, 2018-2029, (USD Million)
Global Immuno-Oncology Treatment total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Immuno-Oncology Treatment market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amgen, AstraZeneca, Bristol-Myers Squibb, Eli-Lilly, Roche, GlaxoSmithKline, Janssen Biotech, Merck and Novartis, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Immuno-Oncology Treatment market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Immuno-Oncology Treatment Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Immuno-Oncology Treatment Market, Segmentation by Type
    Immune Checkpoint Inhibitors
    Monoclonal Antibodies
    Cytokine-Based Immunotherapy
    Cancer Vaccines
    CAR-T Cell Therapy

Global Immuno-Oncology Treatment Market, Segmentation by Application
    Hospitals
    Ambulatory Surgical Center
    Others

Companies Profiled:
    Amgen
    AstraZeneca
    Bristol-Myers Squibb
    Eli-Lilly
    Roche
    GlaxoSmithKline
    Janssen Biotech
    Merck
    Novartis
    Pfizer
    Sanofi
    Spectrum Pharmaceuticals
    Takeda

Key Questions Answered
1. How big is the global Immuno-Oncology Treatment market?
2. What is the demand of the global Immuno-Oncology Treatment market?
3. What is the year over year growth of the global Immuno-Oncology Treatment market?
4. What is the total value of the global Immuno-Oncology Treatment market?
5. Who are the major players in the global Immuno-Oncology Treatment market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Immuno-Oncology Treatment Introduction
    1.2 World Immuno-Oncology Treatment Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Immuno-Oncology Treatment Total Market by Region (by Headquarter Location)
        1.3.1 World Immuno-Oncology Treatment Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Immuno-Oncology Treatment Market Size (2018-2029)
        1.3.3 China Immuno-Oncology Treatment Market Size (2018-2029)
        1.3.4 Europe Immuno-Oncology Treatment Market Size (2018-2029)
        1.3.5 Japan Immuno-Oncology Treatment Market Size (2018-2029)
        1.3.6 South Korea Immuno-Oncology Treatment Market Size (2018-2029)
        1.3.7 ASEAN Immuno-Oncology Treatment Market Size (2018-2029)
        1.3.8 India Immuno-Oncology Treatment Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Immuno-Oncology Treatment Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Immuno-Oncology Treatment Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Immuno-Oncology Treatment Consumption Value (2018-2029)
    2.2 World Immuno-Oncology Treatment Consumption Value by Region
        2.2.1 World Immuno-Oncology Treatment Consumption Value by Region (2018-2023)
        2.2.2 World Immuno-Oncology Treatment Consumption Value Forecast by Region (2024-2029)
    2.3 United States Immuno-Oncology Treatment Consumption Value (2018-2029)
    2.4 China Immuno-Oncology Treatment Consumption Value (2018-2029)
    2.5 Europe Immuno-Oncology Treatment Consumption Value (2018-2029)
    2.6 Japan Immuno-Oncology Treatment Consumption Value (2018-2029)
    2.7 South Korea Immuno-Oncology Treatment Consumption Value (2018-2029)
    2.8 ASEAN Immuno-Oncology Treatment Consumption Value (2018-2029)
    2.9 India Immuno-Oncology Treatment Consumption Value (2018-2029)

3 World Immuno-Oncology Treatment Companies Competitive Analysis
    3.1 World Immuno-Oncology Treatment Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Immuno-Oncology Treatment Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Immuno-Oncology Treatment in 2022
        3.2.3 Global Concentration Ratios (CR8) for Immuno-Oncology Treatment in 2022
    3.3 Immuno-Oncology Treatment Company Evaluation Quadrant
    3.4 Immuno-Oncology Treatment Market: Overall Company Footprint Analysis
        3.4.1 Immuno-Oncology Treatment Market: Region Footprint
        3.4.2 Immuno-Oncology Treatment Market: Company Product Type Footprint
        3.4.3 Immuno-Oncology Treatment Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Immuno-Oncology Treatment Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Immuno-Oncology Treatment Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Immuno-Oncology Treatment Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Immuno-Oncology Treatment Consumption Value Comparison
        4.2.1 United States VS China: Immuno-Oncology Treatment Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Immuno-Oncology Treatment Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Immuno-Oncology Treatment Companies and Market Share, 2018-2023
        4.3.1 United States Based Immuno-Oncology Treatment Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Immuno-Oncology Treatment Revenue, (2018-2023)
    4.4 China Based Companies Immuno-Oncology Treatment Revenue and Market Share, 2018-2023
        4.4.1 China Based Immuno-Oncology Treatment Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Immuno-Oncology Treatment Revenue, (2018-2023)
    4.5 Rest of World Based Immuno-Oncology Treatment Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Immuno-Oncology Treatment Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Immuno-Oncology Treatment Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Immuno-Oncology Treatment Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Immune Checkpoint Inhibitors
        5.2.2 Monoclonal Antibodies
        5.2.3 Cytokine-Based Immunotherapy
        5.2.4 Cancer Vaccines
        5.2.5 CAR-T Cell Therapy
    5.3 Market Segment by Type
        5.3.1 World Immuno-Oncology Treatment Market Size by Type (2018-2023)
        5.3.2 World Immuno-Oncology Treatment Market Size by Type (2024-2029)
        5.3.3 World Immuno-Oncology Treatment Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Immuno-Oncology Treatment Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Hospitals
        6.2.2 Ambulatory Surgical Center
        6.2.3 Others
    6.3 Market Segment by Application
        6.3.1 World Immuno-Oncology Treatment Market Size by Application (2018-2023)
        6.3.2 World Immuno-Oncology Treatment Market Size by Application (2024-2029)
        6.3.3 World Immuno-Oncology Treatment Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Amgen
        7.1.1 Amgen Details
        7.1.2 Amgen Major Business
        7.1.3 Amgen Immuno-Oncology Treatment Product and Services
        7.1.4 Amgen Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Amgen Recent Developments/Updates
        7.1.6 Amgen Competitive Strengths & Weaknesses
    7.2 AstraZeneca
        7.2.1 AstraZeneca Details
        7.2.2 AstraZeneca Major Business
        7.2.3 AstraZeneca Immuno-Oncology Treatment Product and Services
        7.2.4 AstraZeneca Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 AstraZeneca Recent Developments/Updates
        7.2.6 AstraZeneca Competitive Strengths & Weaknesses
    7.3 Bristol-Myers Squibb
        7.3.1 Bristol-Myers Squibb Details
        7.3.2 Bristol-Myers Squibb Major Business
        7.3.3 Bristol-Myers Squibb Immuno-Oncology Treatment Product and Services
        7.3.4 Bristol-Myers Squibb Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Bristol-Myers Squibb Recent Developments/Updates
        7.3.6 Bristol-Myers Squibb Competitive Strengths & Weaknesses
    7.4 Eli-Lilly
        7.4.1 Eli-Lilly Details
        7.4.2 Eli-Lilly Major Business
        7.4.3 Eli-Lilly Immuno-Oncology Treatment Product and Services
        7.4.4 Eli-Lilly Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Eli-Lilly Recent Developments/Updates
        7.4.6 Eli-Lilly Competitive Strengths & Weaknesses
    7.5 Roche
        7.5.1 Roche Details
        7.5.2 Roche Major Business
        7.5.3 Roche Immuno-Oncology Treatment Product and Services
        7.5.4 Roche Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Roche Recent Developments/Updates
        7.5.6 Roche Competitive Strengths & Weaknesses
    7.6 GlaxoSmithKline
        7.6.1 GlaxoSmithKline Details
        7.6.2 GlaxoSmithKline Major Business
        7.6.3 GlaxoSmithKline Immuno-Oncology Treatment Product and Services
        7.6.4 GlaxoSmithKline Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 GlaxoSmithKline Recent Developments/Updates
        7.6.6 GlaxoSmithKline Competitive Strengths & Weaknesses
    7.7 Janssen Biotech
        7.7.1 Janssen Biotech Details
        7.7.2 Janssen Biotech Major Business
        7.7.3 Janssen Biotech Immuno-Oncology Treatment Product and Services
        7.7.4 Janssen Biotech Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Janssen Biotech Recent Developments/Updates
        7.7.6 Janssen Biotech Competitive Strengths & Weaknesses
    7.8 Merck
        7.8.1 Merck Details
        7.8.2 Merck Major Business
        7.8.3 Merck Immuno-Oncology Treatment Product and Services
        7.8.4 Merck Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Merck Recent Developments/Updates
        7.8.6 Merck Competitive Strengths & Weaknesses
    7.9 Novartis
        7.9.1 Novartis Details
        7.9.2 Novartis Major Business
        7.9.3 Novartis Immuno-Oncology Treatment Product and Services
        7.9.4 Novartis Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 Novartis Recent Developments/Updates
        7.9.6 Novartis Competitive Strengths & Weaknesses
    7.10 Pfizer
        7.10.1 Pfizer Details
        7.10.2 Pfizer Major Business
        7.10.3 Pfizer Immuno-Oncology Treatment Product and Services
        7.10.4 Pfizer Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Pfizer Recent Developments/Updates
        7.10.6 Pfizer Competitive Strengths & Weaknesses
    7.11 Sanofi
        7.11.1 Sanofi Details
        7.11.2 Sanofi Major Business
        7.11.3 Sanofi Immuno-Oncology Treatment Product and Services
        7.11.4 Sanofi Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 Sanofi Recent Developments/Updates
        7.11.6 Sanofi Competitive Strengths & Weaknesses
    7.12 Spectrum Pharmaceuticals
        7.12.1 Spectrum Pharmaceuticals Details
        7.12.2 Spectrum Pharmaceuticals Major Business
        7.12.3 Spectrum Pharmaceuticals Immuno-Oncology Treatment Product and Services
        7.12.4 Spectrum Pharmaceuticals Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023)
        7.12.5 Spectrum Pharmaceuticals Recent Developments/Updates
        7.12.6 Spectrum Pharmaceuticals Competitive Strengths & Weaknesses
    7.13 Takeda
        7.13.1 Takeda Details
        7.13.2 Takeda Major Business
        7.13.3 Takeda Immuno-Oncology Treatment Product and Services
        7.13.4 Takeda Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023)
        7.13.5 Takeda Recent Developments/Updates
        7.13.6 Takeda Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Immuno-Oncology Treatment Industry Chain
    8.2 Immuno-Oncology Treatment Upstream Analysis
    8.3 Immuno-Oncology Treatment Midstream Analysis
    8.4 Immuno-Oncology Treatment Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Immuno-Oncology Treatment Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Immuno-Oncology Treatment Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Immuno-Oncology Treatment Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Immuno-Oncology Treatment Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Immuno-Oncology Treatment Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Immuno-Oncology Treatment Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Immuno-Oncology Treatment Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Immuno-Oncology Treatment Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Immuno-Oncology Treatment Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Immuno-Oncology Treatment Players in 2022
    Table 12. World Immuno-Oncology Treatment Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Immuno-Oncology Treatment Company Evaluation Quadrant
    Table 14. Head Office of Key Immuno-Oncology Treatment Player
    Table 15. Immuno-Oncology Treatment Market: Company Product Type Footprint
    Table 16. Immuno-Oncology Treatment Market: Company Product Application Footprint
    Table 17. Immuno-Oncology Treatment Mergers & Acquisitions Activity
    Table 18. United States VS China Immuno-Oncology Treatment Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Immuno-Oncology Treatment Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Immuno-Oncology Treatment Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Immuno-Oncology Treatment Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Immuno-Oncology Treatment Revenue Market Share (2018-2023)
    Table 23. China Based Immuno-Oncology Treatment Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Immuno-Oncology Treatment Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Immuno-Oncology Treatment Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Immuno-Oncology Treatment Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Immuno-Oncology Treatment Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Immuno-Oncology Treatment Revenue Market Share (2018-2023)
    Table 29. World Immuno-Oncology Treatment Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Immuno-Oncology Treatment Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Immuno-Oncology Treatment Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Immuno-Oncology Treatment Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Immuno-Oncology Treatment Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Immuno-Oncology Treatment Market Size by Application (2024-2029) & (USD Million)
    Table 35. Amgen Basic Information, Area Served and Competitors
    Table 36. Amgen Major Business
    Table 37. Amgen Immuno-Oncology Treatment Product and Services
    Table 38. Amgen Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Amgen Recent Developments/Updates
    Table 40. Amgen Competitive Strengths & Weaknesses
    Table 41. AstraZeneca Basic Information, Area Served and Competitors
    Table 42. AstraZeneca Major Business
    Table 43. AstraZeneca Immuno-Oncology Treatment Product and Services
    Table 44. AstraZeneca Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. AstraZeneca Recent Developments/Updates
    Table 46. AstraZeneca Competitive Strengths & Weaknesses
    Table 47. Bristol-Myers Squibb Basic Information, Area Served and Competitors
    Table 48. Bristol-Myers Squibb Major Business
    Table 49. Bristol-Myers Squibb Immuno-Oncology Treatment Product and Services
    Table 50. Bristol-Myers Squibb Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Bristol-Myers Squibb Recent Developments/Updates
    Table 52. Bristol-Myers Squibb Competitive Strengths & Weaknesses
    Table 53. Eli-Lilly Basic Information, Area Served and Competitors
    Table 54. Eli-Lilly Major Business
    Table 55. Eli-Lilly Immuno-Oncology Treatment Product and Services
    Table 56. Eli-Lilly Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Eli-Lilly Recent Developments/Updates
    Table 58. Eli-Lilly Competitive Strengths & Weaknesses
    Table 59. Roche Basic Information, Area Served and Competitors
    Table 60. Roche Major Business
    Table 61. Roche Immuno-Oncology Treatment Product and Services
    Table 62. Roche Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Roche Recent Developments/Updates
    Table 64. Roche Competitive Strengths & Weaknesses
    Table 65. GlaxoSmithKline Basic Information, Area Served and Competitors
    Table 66. GlaxoSmithKline Major Business
    Table 67. GlaxoSmithKline Immuno-Oncology Treatment Product and Services
    Table 68. GlaxoSmithKline Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. GlaxoSmithKline Recent Developments/Updates
    Table 70. GlaxoSmithKline Competitive Strengths & Weaknesses
    Table 71. Janssen Biotech Basic Information, Area Served and Competitors
    Table 72. Janssen Biotech Major Business
    Table 73. Janssen Biotech Immuno-Oncology Treatment Product and Services
    Table 74. Janssen Biotech Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Janssen Biotech Recent Developments/Updates
    Table 76. Janssen Biotech Competitive Strengths & Weaknesses
    Table 77. Merck Basic Information, Area Served and Competitors
    Table 78. Merck Major Business
    Table 79. Merck Immuno-Oncology Treatment Product and Services
    Table 80. Merck Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Merck Recent Developments/Updates
    Table 82. Merck Competitive Strengths & Weaknesses
    Table 83. Novartis Basic Information, Area Served and Competitors
    Table 84. Novartis Major Business
    Table 85. Novartis Immuno-Oncology Treatment Product and Services
    Table 86. Novartis Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. Novartis Recent Developments/Updates
    Table 88. Novartis Competitive Strengths & Weaknesses
    Table 89. Pfizer Basic Information, Area Served and Competitors
    Table 90. Pfizer Major Business
    Table 91. Pfizer Immuno-Oncology Treatment Product and Services
    Table 92. Pfizer Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. Pfizer Recent Developments/Updates
    Table 94. Pfizer Competitive Strengths & Weaknesses
    Table 95. Sanofi Basic Information, Area Served and Competitors
    Table 96. Sanofi Major Business
    Table 97. Sanofi Immuno-Oncology Treatment Product and Services
    Table 98. Sanofi Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 99. Sanofi Recent Developments/Updates
    Table 100. Sanofi Competitive Strengths & Weaknesses
    Table 101. Spectrum Pharmaceuticals Basic Information, Area Served and Competitors
    Table 102. Spectrum Pharmaceuticals Major Business
    Table 103. Spectrum Pharmaceuticals Immuno-Oncology Treatment Product and Services
    Table 104. Spectrum Pharmaceuticals Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 105. Spectrum Pharmaceuticals Recent Developments/Updates
    Table 106. Takeda Basic Information, Area Served and Competitors
    Table 107. Takeda Major Business
    Table 108. Takeda Immuno-Oncology Treatment Product and Services
    Table 109. Takeda Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 110. Global Key Players of Immuno-Oncology Treatment Upstream (Raw Materials)
    Table 111. Immuno-Oncology Treatment Typical Customers
List of Figure
    Figure 1. Immuno-Oncology Treatment Picture
    Figure 2. World Immuno-Oncology Treatment Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Immuno-Oncology Treatment Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Immuno-Oncology Treatment Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Immuno-Oncology Treatment Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Immuno-Oncology Treatment Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Immuno-Oncology Treatment Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Immuno-Oncology Treatment Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Immuno-Oncology Treatment Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Immuno-Oncology Treatment Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Immuno-Oncology Treatment Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Immuno-Oncology Treatment Revenue (2018-2029) & (USD Million)
    Figure 13. Immuno-Oncology Treatment Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Immuno-Oncology Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Immuno-Oncology Treatment Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Immuno-Oncology Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Immuno-Oncology Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Immuno-Oncology Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Immuno-Oncology Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Immuno-Oncology Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Immuno-Oncology Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Immuno-Oncology Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Immuno-Oncology Treatment by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Immuno-Oncology Treatment Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Immuno-Oncology Treatment Markets in 2022
    Figure 27. United States VS China: Immuno-Oncology Treatment Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Immuno-Oncology Treatment Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Immuno-Oncology Treatment Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Immuno-Oncology Treatment Market Size Market Share by Type in 2022
    Figure 31. Immune Checkpoint Inhibitors
    Figure 32. Monoclonal Antibodies
    Figure 33. Cytokine-Based Immunotherapy
    Figure 34. Cancer Vaccines
    Figure 35. CAR-T Cell Therapy
    Figure 36. World Immuno-Oncology Treatment Market Size Market Share by Type (2018-2029)
    Figure 37. World Immuno-Oncology Treatment Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 38. World Immuno-Oncology Treatment Market Size Market Share by Application in 2022
    Figure 39. Hospitals
    Figure 40. Ambulatory Surgical Center
    Figure 41. Others
    Figure 42. Immuno-Oncology Treatment Industrial Chain
    Figure 43. Methodology
    Figure 44. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Immuno-Oncology Treatment Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Immuno-Oncology Treatment Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 08 Jan 2023

date Medical Care

According to our (Global Info Research) latest study, the global Immuno-Oncology Treatment market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global Immuno-Oncology Treatment Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Immuno-Oncology Treatment Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Immuno-Oncology Treatment market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

Immuno-Oncology Treatment

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>